Stockreport

Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears [Yahoo! Finance]

Maze Therapeutics, Inc.  (MAZE) 
PDF Therapeutics (NASDAQ:MAZE) , reported the exercise of 30,000 stock options and immediate sale of the underlying common shares for ~$1.51 million, according to a SEC Form [Read more]